ELF4 and central nervous system cancer: The correlation of IC50 values of the drugs/ compounds with ELF4 expression in the three glioma datasets were calculated and the Motesanib (AMG 706), EHT 1864, Veliparib (ABT-888), CCT007093 were filtered out based on the correlation analysis of compounds with ELF4 |cor|>0.30 and p<0.05 (Fig. 8E).